SAA1 and COVID-19: Liver functions changes and further produces SAA1 and CRP, which have been identified as biomarkers for the severity in COVID-19 patients.12 SAA1 and CRP further activate the complement system to recruit inflammatory cells, increase vascular permeability, and contributing to cytokine storm.